The transcription factor KLF4 as an independent predictive marker for pathologic complete remission in breast cancer neoadjuvant chemotherapy: a case–control study
Min Jun Dong,1 Lin Bo Wang,1 Zhi Nong Jiang,2 Mei Jin,2 Wen Xian Hu,1 Jian Guo Shen1 1Department of Surgical Oncology, 2Department of Pathology, Sir Run Run Shaw Hospital, Zhejiang University College of Medicine, Hangzhou, People's Republic of China Background: To identify whether a stem c...
Main Authors: | Dong MJ, Wang LB, Jiang ZN, Jin M, Hu WX, Shen JG |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-10-01
|
Series: | OncoTargets and Therapy |
Online Access: | http://www.dovepress.com/the-transcription-factor-klf4-as-an-independent-predictive-marker-for--peer-reviewed-article-OTT |
Similar Items
-
Association Between Background Parenchymal Enhancement and Pathologic Complete Remission Throughout the Neoadjuvant Chemotherapy in Breast Cancer Patients
by: Chao You, et al.
Published: (2017-10-01) -
Accurate Prediction of Neoadjuvant Chemotherapy Pathological Complete Remission (pCR) for the Four Sub-Types of Breast Cancer
by: Xin Feng, et al.
Published: (2019-01-01) -
Complete remission of multiple liver metastases with only partial response of the primary rectal cancer after neoadjuvant chemotherapy
by: Satomi Miura, et al.
Published: (2020-02-01) -
Predicting pathological complete response in the axilla post neoadjuvant chemotherapy in carcinoma breast
by: A. AbduRahman, et al.
Published: (2021-04-01) -
Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response
by: Uanderson Resende, et al.
Published: (2019-06-01)